Navigation Links
Cilia guide neuronal migration in developing brain
Date:11/12/2012

A new study demonstrates the dynamic role cilia play in guiding the migration of neurons in the embryonic brain. Cilia are tiny hair-like structures on the surfaces of cells, but here they are acting more like radio antennae.

In developing mouse embryos, researchers were able to see cilia extending and retracting as neurons migrate. The cilia appear to be receiving signals needed for neurons to find their places.

Genetic mutations that cause the neurodevelopmental disorder Joubert syndrome interfere with these migratory functions of cilia, the researchers show. The finding suggests that problems with neuron migration may explain some aspects of Joubert syndrome patients' symptoms.

The results were published in the journal Developmental Cell.

"The most surprising thing was how dynamic the cilia are," says Tamara Caspary, PhD, assistant professor of human genetics at Emory University School of Medicine. "As interneurons migrate into the developing cerebral cortex, they move in steps. When they pause, we could see the cilia extending, as if the interneurons are trying to figure out where to go next."

The paper is the result of a collaboration between Caspary's laboratory and that of Eva Anton, PhD, professor of cell and molecular physiology at University of North Carolina School of Medicine. First author Holden Higginbotham, formerly a postdoc in Anton's laboratory, is now a faculty member at Brigham Young University in Idaho.

Readers may be familiar with motile cilia, which can be found on a paramecium or in our trachea or reproductive organs. In contrast, primary (non-motile) cilia can be found on almost every cell in the human body, each cell having just one. Ciliopathies are a class of genetic disorders involving defects in cilia, and include kidney and eye diseases as well as Joubert syndrome.

Joubert syndrome affects the development of the cerebellum and brain stem, leading to lack of muscle control, breathing problems, and sometimes intellectual disability.

Caspary's laboratory has been studying Arl13b, a gene mutated in Joubert syndrome. Mutations in Arl13b lead to cilia that are short and stubby.

"It's a useful tool for studying the role of cilia in development, because it doesn't take a sledgehammer to the entire structure," Caspary says.

Exactly how Arl13b contributes to the function of cilia is unclear it appears to be involved in protein transport needed for building cilia because when it is hyperactivated, cilia are longer.

Caspary's and Anton's laboratories teamed up to look at neuronal migration in mouse embryos where Arl13b was deleted, but only in some types of neurons. "Interneurons" form connections between other neurons and do not connect to muscles or sensory organs. They observed that when Arl13b was deleted in interneurons, those cells did not migrate properly through the developing cortex of the brain.

The team probed cilia by using mice that produced a red fluorescent protein within cilia. Slices of embryonic brain were examined with a confocal microscope, under conditions where the cells stay alive and continue moving for several hours.

The scientists could see the interneurons migrating in spurts, with the cilia tending to extend and move "like basketball players' arms" when the cells paused. In the Arl13b deleted mice, the cilia did not extend as much and often could be seen only as red dots. Reintroducing Arl13b could rescue these defects, while a form of Arl13b found in Joubert syndrome patients could not.

How defects in cilia contribute to Joubert syndrome is complex; cilia are needed for Hedgehog signaling, machinery that controls embryonic patterning. Caspary says the neuron migration problem may explain the intellectual disability aspect, while Hedgehog defects may explain impaired development of the cerebellum and brainstem.


'/>"/>
Contact: Quinn Eastman
qeastma@emory.edu
404-727-7829
Emory University
Source:Eurekalert

Related biology news :

1. Optical waveguide connects semiconductor chips
2. DNA sequences need quality time too - guidelines for quality control published
3. A practical guide to green products and services
4. Computer scientists develop an interactive field guide app for birders
5. New analysis helps guide use of erlotinib in advanced non-small cell lung cancer
6. Lower dosage CT-guided lung biopsy protocol maintains quality, minimizes exposure
7. Canadian Journal of Cardiology publishes new atrial fibrillation guidelines
8. UC research tests new tool to guide reintroduction of the American chestnut
9. Newly released FDA draft guidelines for biosimilar drugs to be discussed at conference
10. EU FET program funds research on 3D neuronal structures mimicking human brain tissue
11. Ion selectivity in neuronal signaling channels evolved twice in animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
(Date:2/24/2017)... Feb. 24, 2017 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced its unaudited financial results for the third quarter ... December 31, 2016. Third Quarter of Fiscal ... quarter of fiscal 2017 increased by 18.6% to RMB200.9 ...
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ... immunotherapies, will host a Key Opinion Leader event to ... an oral and poster presentation at the upcoming 2017 ... The KOL event will be held in-person and via ... EST / 9:00 AM PST at the Lotte New ...
(Date:2/23/2017)... 2017 /PRNewswire/ - The Fight Against Cancer Innovation Trust ... are pleased to report that Fusion Pharmaceuticals Inc. (Fusion) ... & Johnson Innovation – JJDC, Inc. (JJDC) as the ... TPG Biotechnology Partners, and Genesys Capital, as well as ... ...
Breaking Biology Technology: